Literature DB >> 10529239

Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments.

A Bini1, D Wu, J Schnuer, B J Kudryk.   

Abstract

Matrix metalloproteinases (MMPs) participate in physiological remodeling of the extracellular matrix. Recently we determined that both fibrinogen (Fg) and cross-linked fibrin (XL-Fb) are substrates for selected MMPs. Specifically, XL-Fb clots were solubilized by MMP-3 (stromelysin 1) by cleavage at gamma Gly 404-Ala 405, resulting in a D-like monomer fragment. Similarly, MMP-7 (matrilysin) and MT1-MMP (membrane type 1 matrix metalloproteinase) solubilized XL-Fb clots. However, the molecular mass of fragment D-dimer, obtained after MMP-7 and MT1-MMP degradation of XL-Fb, is similar to that of fragment D-dimer from plasmin degradation ( approximately 186 kDa). In contrast, fragment D-like monomer, from MMP-3 degradation of both fibrinogen (Fg) and XL-Fb, is similar to fragment D from plasmin degradation of Fg ( approximately 94 kDa). Reduced chains from MMP-3, MMP-7, and MT1-MMP digests of Fg and XL-Fb were subjected to direct sequence analyses and D/D-dimer alpha-chain showed cleavage at both alpha Asp 97-Phe 98 and alpha Asn 102-Asn 103. Degradation of the beta-chain resulted in microheterogeneity of cleavage sites at beta Asp 123-Leu 124, beta Asn 137-Val 138, and beta Glu 141-Tyr 142, whereas all three enzymes cleaved the gamma-chain at gamma Thr 83-Leu 84. In both Fg and XL-Fb, several cleavage sites obtained by proteolysis with MMP-3, MMP-7, and MT1-MMP were found to be in very close proximity to those obtained by plasmin on these same substrates. That does not occur with other MMPs such as MMP-1, -2, and -9 and MT2-MMP. The degradation of XL-Fb by MMPs suggests both plasmin-dependent and independent mechanisms of fibrinolysis that might be relevant in inflammation, angiogenesis, arthritis, and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529239     DOI: 10.1021/bi991096g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

Review 1.  A fibrin based model for rheumatoid synovitis.

Authors:  O Sánchez-Pernaute; R Largo; E Calvo; M A Alvarez-Soria; J Egido; G Herrero-Beaumont
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

Review 2.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

3.  Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.

Authors:  Michael R Zile; Catalin F Baicu; Robert E Stroud; An Van Laer; Jazmine Arroyo; Rupak Mukherjee; Jeffrey A Jones; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

4.  Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism.

Authors:  Cara-Lynn E Helm; Mark E Fleury; Andreas H Zisch; Federica Boschetti; Melody A Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-25       Impact factor: 11.205

5.  Enhanced fibrinolysis in fingerstick blood samples: a possible role for matrix metalloproteinase-9.

Authors:  Rachna Vanjani; Melissa Park; Brittany Holt; Ann Cullinane; Paula Merryman; McDonald Horne
Journal:  Thromb Res       Date:  2007-04-03       Impact factor: 3.944

6.  Temporal changes in microvessel leakiness during wound healing discriminated by in vivo fluorescence recovery after photobleaching.

Authors:  Maria J C Machado; Christopher A Mitchell
Journal:  J Physiol       Date:  2011-07-18       Impact factor: 5.182

7.  Phenotypic Screening To Discover Novel Chemical Series as Efficient Antihemorrhagic Agents.

Authors:  Irene de Miguel; Josune Orbe; Juan A Sánchez-Arias; José A Rodríguez; Agustina Salicio; Obdulia Rabal; Miriam Belzunce; Elena Sáez; Musheng Xu; Wei Wu; Haizhong Tan; Hongyu Ma; José A Páramo; Julen Oyarzabal
Journal:  ACS Med Chem Lett       Date:  2018-04-16       Impact factor: 4.345

8.  Regulated expression of matrix metalloproteinases, inflammatory mediators, and endometrial matrix remodeling by 17beta-estradiol in the immature rat uterus.

Authors:  Louise A Russo; Bryan J Peano; Shreya P Trivedi; Todd D Cavalcanto; Benjamin A Olenchock; Joseph A Caruso; Amanda R Smolock; Oleg Vishnevsky; Russell M Gardner
Journal:  Reprod Biol Endocrinol       Date:  2009-11-04       Impact factor: 5.211

9.  Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis.

Authors:  Xuefeng B Ling; Kenneth Lau; Chetan Deshpande; Jane L Park; Diana Milojevic; Claudia Macaubas; Chris Xiao; Viorica Lopez-Avila; John Kanegaye; Jane C Burns; Harvey Cohen; James Schilling; Elizabeth D Mellins
Journal:  Clin Proteomics       Date:  2010-09-30       Impact factor: 3.988

10.  The transcriptome of cervical ripening in human pregnancy before the onset of labor at term: identification of novel molecular functions involved in this process.

Authors:  Sonia S Hassan; Roberto Romero; Adi L Tarca; Chia-Ling Nhan-Chang; Edi Vaisbuch; Offer Erez; Pooja Mittal; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Lami Yeo; Sorin Draghici; Jung-Sun Kim; Niels Uldbjerg; Chong Jai Kim
Journal:  J Matern Fetal Neonatal Med       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.